8月7日 - ** 仿制药生产商Viatris VTRS.O股价盘前上涨3.9%至9.09美元
** VTRS第二季度每股利润为62美分，而分析师预计为56美分--数据由LSEG汇编
** 季度营收为 35.8 亿美元，预期为 34.7 亿美元
** 公司重申 2025 年收入预期在 135 亿至 140 亿美元之间
** 还重申其年度每股利润介于 2.16 美元和 2.30 美元之间
** 截至上一交易日收盘，股价累计下跌 29.7
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.